Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
Top Cited Papers
Open Access
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 132 (3) , 863-873
- https://doi.org/10.1053/j.gastro.2006.12.003
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2006
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialPublished by Elsevier ,2002
- Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patientsAmerican Journal of Gastroenterology, 2001
- Infliximab in Crohn's Disease: First Anniversary Clinical ExperienceAmerican Journal of Gastroenterology, 2000
- Prolonged duration of response to infliximab in early but not late pediatric Crohn's diseaseAmerican Journal of Gastroenterology, 2000
- Use of infliximab in the treatment of Crohn's disease in children and adolescentsThe Journal of Pediatrics, 2000
- Bone Mineral Density in Children and Young Adults with Crohnʼs DiseaseInflammatory Bowel Diseases, 1999
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- Growth failure in children with inflammatory bowel disease: A prospective studyGastroenterology, 1993